Have a symptom?
See what questions
a doctor would ask.
News » NIAID talks down concerns over HIV/AIDS drug

NIAID talks down concerns over HIV/AIDS drug

Even though further studies of it's side effects will be conducted, the NIAID claims that Nevirapine (protects newborns from infection of HIV/AIDS from infected mother) is safe and effective to use in pregnant women. A clinical trial in Uganda had raised some concerns about the drugs but they were ignored. The US will reevaluate the methodology and results of the clinical trial to allay any concerns. The drug is believed to reduce the risk of infection from mother to child by up to 50%.

Source: summary of medical news story as reported by All Africa

Related Disease Topics:

Article Source Details

About: NIAID talks down concerns over HIV/AIDS drug

Date: 15 December 2004

Source: All Africa


Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • Fibroymalia is an underdiagnosed condition which is finally gaining recognition
  • First long term survivor of CJD saved by experimental drug
  • First Vioxx trial set for May
  • Fish oils improve child behavior
  • Fish oils preventative effect on childhood asthma discovered
  • Fitter people have an improved blood pressure response to stress
  • Flawed asthma studies promote long-term use of potentially harmful asthma drug
  • Flu pandemic expected to hit this winter
  • Flu vaccination recommended for children with conditions
  • Foetus dies after mother suffers gastric stapling complications

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise